Featured News

A large study of the population in Taiwan reveals that long-term use of benzodiazepine drugs, commonly prescribed for anxiety, significantly increases the risk for brain, colorectal, and lung cancers. The research, published open-access in the journal Medicine, also identifies the types of benzodiazepines that carry the greatest cancer risk.

Lithium appears to reduce libido and sexual function, and more research into the problem is needed.

MIA’s Justin Karter interviews critical psychiatrist and philosopher Pat Bracken about the necessity of challenging received wisdom.

New research explores the use of broad-based school-integrated resiliency and mindfulness interventions to prevent mental health concerns before they occur.

MIA’s Hannah Emerson interviews Comas-Díaz on the need for culturally competent care in a medicalized and individualistic society.

A new article reviews studies in the field of nutritional psychiatry and how nutrition can prevent and treat mental health issues.

A new review of antipsychotic trials conducted over the last 24 years finds that the placebo response rate is steadily increasing, and drug response is decreasing.

A third of patients who have taken the common psychiatric medication lithium for over ten years have developed "chronic renal failure" from the drug.

Common scientific beliefs about serotonin levels in depression and how antidepressants act on the brain appear to be completely backwards.

A new systematic review finds that patients report reduced symptoms but also loss of self and agency while taking antipsychotics.

Studies that compare the effectiveness of different antidepressant drugs are unreliable, according to new research in BMC Psychiatry.

Taking an SSRI antidepressant was associated with a 26% increased risk of violent crime conviction.

Neuropsychological assessments reveal the cognitive, occupational, and social impact of polypharmacy in psychiatry.

Researchers suggest that the pharmaceutical industry had a vested interest in using the term “discontinuation” in order to hide the severity of physical dependence and withdrawal reactions many people experience from antidepressants.

In this month’s issue of the journal Brain a new study investigates whether the drugs prescribed to control seizures can increase the risk of...

An issue of Lancet Psychiatry is devoted to clarifying the lack of efficacy for Zoloft (sertraline).

Jürgen Margraf and Silvia Schneider, both well-known psychologists at the University of Bochum in Germany, claim that psychotropic drugs are no solution to mental...

A new review of strategies to support both patients and practitioners through the process of discontinuing antidepressants.

A new review, published in BMJ Evidence-Based Medicine, concludes that antidepressants should not be used as the risks outweigh evidence for benefits.

A new study by Peter Groot and Jim van Os investigated whether tapering strips can help people stop using antidepressants.

In a new study published in the Journal of Clinical Psychology, researchers tested how well “ontological insecurity” predicted psychotic-like experiences (PLEs). They found that...

Last week, well-known Stanford scientist John Ioannidis and his colleague Denes Szucs released a new analysis online. They examined research published in eighteen prominent...

Once an appropriate statistical method was used, the study findings were “no longer valid,” according to the editors of JAMA and JAMA Psychiatry.

While a great deal of the excitement about advances in psychological treatments comes from the potential for research in neuroscience to unlock the secrets of the brain, many mental health experts would like to temper this enthusiasm. A special issue of the Behavior Therapist released this month calls into question the predominant conception of mental illnesses as brain disorders.

MIA's Tim Beck interviews psychologist Ian Tucker about the relationships between digital technologies, emotion, and mental health.